13F Holdings
中文EN

HSIC HENRY SCHEIN INC

Wholesale-Medical, Dental & Hospital Equipment & Supplies · Nasdaq · SEC CIK 1000228 · Fiscal year ends 12/26

Financial factors as of 2026-09-26 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.2%
TTM net income YoY7.7%
TTM EPS YoY15.1%
Revenue 3-yr CAGR2.7%
Net income 3-yr CAGR-1.8%

Margins

Gross margin31.6%
Operating margin5.2%
Net margin3.1%
FCF margin4.1%
EBITDA margin7.6%

Returns

ROE12.9%
ROA3.7%
ROIC (approx.)8.5%
Asset turnover1.22x

Leverage & solvency

Liabilities / assets58.9%
Debt / equity1.07x
Current ratio1.33x
Interest coverage4.35x

Cash quality & payout

Operating cash flow / net income1.63x
Accruals ratio-2.4%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-27FY20242024-12-28FY20232023-12-30FY20222022-12-31FY20212021-12-25
Income statement
Revenue$13.18B$12.67B$12.34B$12.65B$12.40B
Cost of revenue$9.08B$8.66B$8.48B$8.82B$8.73B
Gross profit$4.11B$4.02B$3.86B$3.83B$3.67B
SG&A expense$3.08B$3.03B$2.96B$2.77B$2.63B
Operating income$653.00M$621.00M$615.00M$747.00M$852.00M
Interest expense$150.00M$131.00M$87.00M$35.00M$27.00M
Pretax income$533.00M$513.00M$542.00M$721.00M$831.00M
Income tax$126.00M$128.00M$120.00M$170.00M$198.00M
Net income$398.00M$390.00M$416.00M$538.00M$631.00M
EBITDA$964.00M$918.00M$863.00M$959.00M$1.06B
EPS (basic)3.293.073.183.954.51
EPS (diluted)3.273.053.163.914.45
Weighted avg. shares (diluted)121.72M127.78M131.75M137.76M141.77M
Balance sheet
Cash & equivalents$156.00M$122.00M$171.00M$117.00M$118.00M
Receivables$1.65B$1.48B$1.86B$1.44B$1.45B
Inventory$2.00B$1.81B$1.81B$1.96B$1.86B
Current assets$4.46B$3.98B$4.49B$3.99B$3.84B
PP&E, net$621.00M$531.00M$498.00M$383.00M$366.00M
Goodwill$4.21B$3.89B$3.88B$2.89B$2.85B
Intangibles$1.02B$1.02B$916.00M$587.00M$668.00M
Total assets$11.21B$10.22B$10.57B$8.61B$8.48B
Current liabilities$3.23B$2.80B$2.68B$2.22B$2.31B
Short-term debt$764.00M$650.00M$264.00M$103.00M$51.00M
Long-term debt$2.31B$1.83B$1.94B$1.04B$811.00M
Total debt$3.07B$2.48B$2.20B$1.14B$862.00M
Total liabilities$6.42B$5.38B$5.42B$3.94B$3.81B
Shareholders' equity$3.25B$3.39B$3.65B$3.45B$3.42B
Net debt$2.92B$2.36B$2.03B$1.03B$744.00M
Shares outstanding115.77M124.16M129.25M131.79M137.15M
Cash flow statement
Operating cash flow$712.00M$848.00M$500.00M$602.00M$710.00M
Capital expenditure$139.00M$148.00M$147.00M$96.00M$79.00M
Free cash flow$573.00M$700.00M$353.00M$506.00M$631.00M
Investing cash flow-$400.00M-$430.00M-$1.14B-$276.00M-$677.00M
Financing cash flow-$188.00M-$510.00M$701.00M-$315.00M-$333.00M
Depreciation & amortization$311.00M$297.00M$248.00M$212.00M$210.00M
Stock-based compensation$39.00M$39.00M$39.00M$54.00M$78.00M
Share buybacks$850.00M$385.00M$250.00M$485.00M$401.00M

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.